I. SNAPPER, M.D.; B. SCHNEID, M.D.
It has been reported previously that in many cases of multiple myeloma injections of stilbamidine—occasionally of pentamidine—exert a favorable influence upon the excruciating pains from which the patients so frequently suffer.1, 2, 3, 4 From the beginning it has been emphasized that the disease is not cured by stilbamidine. Even in patients who are markedly relieved, the characteristic myeloma cells still abound in the bone marrow, and Bence Jones proteinuria and hyperglobulinemia continue unabated. At the very best the disease may be halted temporarily. In some patients the relief of pains has persisted for many months. In many cases the
Learn more about subscription options.
Register Now for a free account.
SNAPPER I, SCHNEID B. THE DEVELOPMENT OF BASOPHILIC INCLUSION BODIES IN MYELOMA CELLS AFTER STILBAMIDINE TREATMENT(THE DEVELOPMENT OF BASOPHILIC INCLUSION BODIES IN MYELOMA CELLS AFTER STILBAMIDINE TREATMENT*). Ann Intern Med. 1947;27:541–547. doi: 10.7326/0003-4819-27-4-541
Download citation file:
Published: Ann Intern Med. 1947;27(4):541-547.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only